Eric Morand gives his thoughts on the FDA approval of anifrolumab for SLE and discusses the need for additional studies to understand exactly how the drug should be used in routine clinical practice.
Remember to like and subscribe to stay up to date with the latest from Medicine Matters rheumatology, alternatively visit us at bit.ly/2U6Vxhi
Негізгі бет FDA approval of anifrolumab for SLE | Eric Morand
Пікірлер